Notice for Annual General meeting to be conducted on 30.09.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Drugs Limited has submitted its Annual Report for FY 2024-25 to BSE and notified its 30th AGM to be held on September 30, 2025 at 09:30 AM through video conferencing (VC/OAVM). The Register of Members will remain closed from September 24 to September 30, 2025, with the e-voting record date set as September 23, 2025 and the e-voting window running from September 27 (9:00 AM) to September 29 (5:00 PM). Shareholders will vote on ordinary business (adoption of FY25 financials, re-appointment of a rotating director) and special business, including approval of related party transactions up to Rs. 15 crore each with four related entities (Proton Remedies, Cortex Laboratories, Seelam Laboratories, Continental Pellets Pharma), ratification of cost auditor remuneration (Rs. 1 lakh), appointment of a new secretarial auditor for 5 years, induction of a new independent director, and re-appointment of three promoter executive directors with specified monthly remuneration.
This is a routine AGM notice with multiple corporate actions requiring shareholder approval. Investors should watch the related party transaction approvals (Rs. 15 crore each with four promoter-linked entities) and the re-appointment of promoter directors with defined remuneration, as these are key governance and conflict-of-interest items affecting minority shareholders.